Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Dr. Jin Yin is a Director of Biologics Process Development at Momenta Pharmaceuticals, leading the upstream group developing manufacturing processes for both biosimilars and novel drugs. Prior to joining Moment in 2016, Jin had worked as an Associate Director at Sanofi Genzyme, a principal engineer at Shire, and a development scientist at GSK.
Jin has about 15-year industry experience in upstream process development, process characterization, bioreactor scale-up and scale-down, process transfer, GMP manufacturing support, and CDMO management. He has a Ph.D. degree in Chemical Engineering from Tsinghua University in Beijing, China and received his postdoctoral training in Professor Daniel Wang’s lab at MIT.